On the other side, the NSC120686 compound was recently identified based on virtual screening of pharmacophores able to inhibit human Tdp1 (Weidlich et al., 2010) and subsequently used in combination with CPT-derivates to inhibit the growth of different cancer cell lines (Perego et al., 2012). The gene discussed is TDP1; the disease is cancer.